imiquimod has been researched along with Lupus Erythematosus, Discoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hassan, S; Patel, V; Safadi, MG; Viglione, M; Zahner, SL | 1 |
| Salih Gurel, M; Sinem Bagci, I; Turan, E; Turgut Erdemir, A | 1 |
| Bieber, T; Gerdsen, R; Petrow, W; Uerlich, M; Wenzel, J | 1 |
1 review(s) available for imiquimod and Lupus Erythematosus, Discoid
| Article | Year |
|---|---|
Successful treatment of generalized discoid lupus erythematosus with imiquimod cream 5%: a case report and review of the literature.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Lupus Erythematosus, Discoid; Male; Middle Aged | 2014 |
2 other study(ies) available for imiquimod and Lupus Erythematosus, Discoid
| Article | Year |
|---|---|
Imiquimod-induced hypertrophic lupus erythematosus-like reaction.
Topics: Aged, 80 and over; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Immunologic Factors; Interferons; Lupus Erythematosus, Discoid; Skin Neoplasms; Toll-Like Receptor 7 | 2022 |
Successful treatment of chronic discoid lupus erythematosus of the scalp with imiquimod.
Topics: Administration, Topical; Aminoquinolines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Lupus Erythematosus, Discoid; Middle Aged; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2002 |